Levalbuterol Tartrate Hfa Inhalation Aerosol, Metered
Product Images NDC 0591-2927

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Levalbuterol Tartrate Hfa Inhalation (NDC 0591-2927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram depicting the molecular structure of levalbuterol tartrate, showing the arrangement of atoms and bonds characteristic to this active ingredient used in the inhalation aerosol form.*

FDA Label Image

Image 10

An instructional illustration showing a person holding a metered-dose inhaler near their mouth, demonstrating the correct use technique by positioning the mouthpiece outward and suggesting inhalation as indicated by directional arrows around the face and inhaler.*

FDA Label Image

Image 11

An instructional illustration showing a person holding a metered dose inhaler close to their mouth with one finger placed on the center of the targeting rings on the inhaler mouthpiece. The image demonstrates proper inhaler positioning for use.*

FDA Label Image

Image 12

An instructional illustration showing a hand rinsing the mouthpiece of an aerosol inhaler, identified as a metered-dose inhaler, under a running faucet. A cap and additional inhaler container are visible nearby on the sink surface.*

FDA Label Image

Image 13

An instructional illustration showing hands removing the canister from the plastic actuator of an inhaler, indicated by an upward arrow. This likely demonstrates a step in preparing or cleaning a metered-dose inhaler device.*

FDA Label Image

Image 14

An instructional illustration showing a hand holding a Levalbuterol tartrate HFA inhalation aerosol against a background with a sink and faucet. The image demonstrates how to use the inhaler, depicting the device being tilted and the spray being released downward into the sink.*

FDA Label Image

Image 15

Instructional illustration showing proper finger placement on the center of targeting rings for actuating a metered-dose inhaler. The top image indicates an unclogged aerosol spray, while the bottom image shows a clogged spray with reduced aerosol output.*

FDA Label Image

Image 16

Packaging label for Levalbuterol tartrate HFA inhalation aerosol by Actavis Pharma, Inc. The label indicates 45 mcg per actuation strength in a 15g canister with 200 metered inhalations. Directions specify use with Xopenex HFA actuator only and oral route. The label includes warnings, storage instructions, pharmacist and patient information, and barcode with NDC 0591-2927-54.*

FDA Label Image

Image 2

A line graph depicting mean percent change in FEV1 over time (hours) on Day 1 for three groups: Levalbuterol tartrate HFA inhalation aerosol, Racemic Albuterol HFA 180 mcg, and placebo. The horizontal axis represents time in hours from 0 to 6, and the vertical axis shows percent change up to 30%. Each group is represented by distinct symbols and sample sizes are noted.*

FDA Label Image

Image 3

A line chart illustrating the mean percentage change in FEV1 over time (hours) up to 6 hours on Day 56. It compares Levalbuterol tartrate HFA inhalation aerosol, Racemic Albuterol HFA 180 mcg, and Placebo groups, showing their respective responses.*

FDA Label Image

Image 4

An instructional diagram showing a Levalbuterol tartrate HFA inhaler from side and top views. Labels identify the canister, actuator, mouthpiece, and cap on the side, and the dose indicator window, pointer, press area, and targeting rings on the top view of the inhaler. This diagram visually explains the inhaler's components and dose counting features.*

FDA Label Image

Image 5

Illustration showing three circular dials or counters with numerical scales indicating spray counts: Figure 2a reads from 80 to 200 sprays, Figure 2b reads from 180 to 200 sprays, and Figure 2c reads from 50 to 180 to 20 sprays. These dials likely represent meter dose inhaler spray counters.*

FDA Label Image

Image 6

Illustration labeled Figure 2d showing a circular dial with three numbers (0, 20, 40) arranged clockwise. An arrow points toward the number 20 inside the dial, which is divided into concentric rings.*

FDA Label Image

Image 7

An instructional illustration showing hands holding a Levalbuterol tartrate HFA inhalation aerosol device. One hand holds the inhaler while the other removes the protective cap from the mouthpiece, demonstrating proper preparation for use.*

FDA Label Image

Image 8

An instructional illustration showing a person holding a metered-dose inhaler with the mouthpiece facing them. The hand is positioned to press down the inhaler, indicated by arrows demonstrating the downward and forward motion, suggesting the correct way to actuate the inhaler for oral administration.*

FDA Label Image

Image 9

An instructional illustration showing a person holding and pressing down on the top of a metered-dose inhaler aerosol canister, aimed towards the mouth. An arrow indicates the direction to press the top of the inhaler to release the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.